Blood Glucose Management in Intensive Care Units

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

525 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-20

Study Completion Date

2024-03-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators propose to conduct a study of practices to describe the methods of managing glycemic control in hospitalized patients in critical care. This is a prospective multicenter observational study conducted in Intensive Medicine and Resuscitation departments in France and Belgium. The aim of this study is to carry out an inventory of the current practices of glycemia management as well as their modalities. Being one of the key points of the management, this work will have for main objective to raise the importance of the glycemic variabilities according to the methods of insulin therapies used.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

NCT00288743

Critically Ill Patients

COMPLETED PHASE2

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.

NCT02244073

Critical Illness

TERMINATED NA

Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU

NCT00591071

Hyperglycemia Critically Ill Patients

UNKNOWN PHASE3

Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients

NCT00107601

Critical Illness

COMPLETED NA

Tight Glycemic Control in Critical Care Patients

NCT00096421

Critical Illness Hyperglycemia Insulin Resistance

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insulin Hypoglycemia Glucose Test Site Bleeding Hyperglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insulin

insulin therapy

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with hyperglycaemia requiring an insulin prescription within 48 hours of admission
* Insulin therapy started less than 12 hours before inclusion of the patient in the study
* Expected duration of hospitalization greater than or equal to 48 hours

Exclusion Criteria

* Moribund patients
* Patients admitted for ketoacidosis or hyperosmolar coma
* Patients admitted for symptomatic hypoglycaemia
* Patient requiring insulin for serum potassium correction
* Severe acute hepatocellular insufficiency
* Age \< 18 years old
* Pregnant or breastfeeding women
* Patients under legal protection measures

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No